Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Short term Debt (2018 - 2025)

PAVmed has reported Short term Debt over the past 5 years, most recently at $11.1 million for Q4 2025.

  • For Q4 2025, Short term Debt fell 61.86% year-over-year to $11.1 million; the TTM value through Dec 2025 reached $11.1 million, down 61.86%, while the annual FY2025 figure was $11.1 million, 61.86% down from the prior year.
  • Short term Debt for Q4 2025 was $11.1 million at PAVmed, up from $6.9 million in the prior quarter.
  • Over five years, Short term Debt peaked at $45.5 million in Q1 2024 and troughed at $260000.0 in Q2 2023.
  • A 4-year average of $26.2 million and a median of $29.5 million in 2022 define the central range for Short term Debt.
  • Biggest five-year swings in Short term Debt: tumbled 99.12% in 2023 and later soared 16823.08% in 2024.
  • Year by year, Short term Debt stood at $33.6 million in 2022, then skyrocketed by 31.35% to $44.2 million in 2023, then tumbled by 34.16% to $29.1 million in 2024, then tumbled by 61.86% to $11.1 million in 2025.
  • Business Quant data shows Short term Debt for PAVM at $11.1 million in Q4 2025, $6.9 million in Q3 2025, and $6.8 million in Q2 2025.